GTR 100004294
Tenders Are Invited For Antineoplastic And Immunomodulating Agency - Antineoplastic And Immunosuppressive Medicines
ICB — International Competitive Bid
Closed
Northern Europe
Tender Information
GTR Reference
100004294
Tendering Authority
Subscribe to view
Tender No
506255-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Antineoplastic And Immunomodulating Agency - Antineoplastic And Immunosuppressive Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Northern Europe
Political Region
European Union
Last Date of Bid Submission
02-09-2025
Closed
Work Detail
Antineoplastic And Immunomodulating Agency - Antineoplastic And Immunosuppressive Medicines. L01aa01 Cyclophosphamide,L01aa03 Melphalan,L01aa06 Ifosfams,L01ax03 Temozolomid,L01ax03 Temozolomid,L01ab01 Business,L01ac01 Thikea,L01ac01 Thikea,L01ba01 Methotrexat,L01ba01 Methotrexat,L01bb04 Kladribiin,L01bb05 Fludarabine,L01bc01 Cytarabine,L01bc02 Fluorouracil,L01bc05 Gemcitabine,L01ca01 Vinblastin,L01ca02 Vincistin,L01cb01 Etoposid,L01cb01 Etoposid,L01cd01 Paclitaxel,L01db01 Doxorubicin,L01db02 Doungorubin,L01db06 Idarubicin,L01db07 Mitoxantrone,L01dc01 Bleomycin,L01dc03 Mitomycin,L01dc03 Mitomycin,L01ef01 Cetuximab,L01xa01 Cisplatin,L01xa02 Carboplatin,L01xa03 Oxaliplatin,L01xf01 Tretionin,L01xc12 Bentruximab Vedotin,L01xc80 They Started Dioximabs,L01xx02 Asparaginase,L01eg01 Temsorolimus,L01eb03 Aftinib,L01eb03 Aftinib,L01ce01 Topotecan,L01ce02 Irinotecan,L01xg03 Ixazombi,L01xg03 Ixazombi,L03ax03 Bcg Vaccine,L03ax15 Mifamurtid,L04aa04 Anti-T-Lymphocyte Immunoglobulin,L04aa06 Mycophenolic Acid,L04aa06 Mycophenolic Acid,L04aaa333 Vedolizumab,L04ad02 Tacrolimus,L04ad02 Tacrolimus
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
3a0130b9-df48-4bdb-8d21-2d814a0f7377.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.